Volume 140, Issue 1, Pages (January 2011)

Slides:



Advertisements
Similar presentations
Volume 72, Issue 2, Pages (July 2007)
Advertisements

Volume 132, Issue 1, Pages (January 2007)
Volume 8, Issue 5, Pages (May 2017)
MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice  Shrikant R. Mulay, Dana Thomasova, Mi Ryu,
Volume 140, Issue 2, Pages e7 (February 2011)
Volume 144, Issue 3, Pages e1 (March 2013)
Volume 129, Issue 5, Pages (November 2005)
Volume 141, Issue 5, Pages e10 (November 2011)
Volume 144, Issue 5, Pages e10 (May 2013)
Serotonin Has a Key Role in Pathogenesis of Experimental Colitis
Volume 140, Issue 2, Pages e2 (February 2011)
Xiaolun Sun, Deborah Threadgill, Christian Jobin  Gastroenterology 
Volume 143, Issue 5, Pages e1 (November 2012)
Activation of Pattern Recognition Receptors Up-Regulates Metallothioneins, Thereby Increasing Intracellular Accumulation of Zinc, Autophagy, and Bacterial.
Volume 134, Issue 7, Pages (June 2008)
Volume 132, Issue 1, Pages (January 2007)
Volume 133, Issue 5, Pages (November 2007)
Volume 135, Issue 2, Pages e3 (August 2008)
Volume 124, Issue 5, Pages (May 2003)
Volume 136, Issue 2, Pages (February 2009)
Volume 140, Issue 2, Pages e7 (February 2011)
Growth Hormone Inhibits Signal Transducer and Activator of Transcription 3 Activation and Reduces Disease Activity in Murine Colitis  Xiaonan Han, Danuta.
Volume 133, Issue 6, Pages (December 2007)
Aryl Hydrocarbon Receptor Regulates Pancreatic IL-22 Production and Protects Mice From Acute Pancreatitis  Jing Xue, David T.C. Nguyen, Aida Habtezion 
Volume 143, Issue 5, Pages e4 (November 2012)
Volume 132, Issue 1, Pages (January 2007)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 137, Issue 4, Pages e5 (October 2009)
Volume 142, Issue 2, Pages (February 2012)
Reduced Expression of UGT1A1 in Intestines of Humanized UGT1 Mice via Inactivation of NF-κB Leads to Hyperbilirubinemia  Ryoichi Fujiwara, Shujuan Chen,
Volume 140, Issue 2, Pages e7 (February 2011)
Volume 141, Issue 5, Pages (November 2011)
Volume 134, Issue 1, Pages e1 (January 2008)
Volume 137, Issue 3, Pages (September 2009)
Volume 140, Issue 1, Pages (January 2011)
Volume 155, Issue 2, Pages (August 2018)
Volume 141, Issue 3, Pages (September 2011)
Volume 145, Issue 3, Pages e3 (September 2013)
Volume 137, Issue 4, Pages (October 2009)
Volume 139, Issue 1, Pages e6 (July 2010)
Xiaolun Sun, Deborah Threadgill, Christian Jobin  Gastroenterology 
Volume 136, Issue 2, Pages (February 2009)
Volume 139, Issue 6, Pages (December 2010)
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 140, Issue 2, Pages e4 (February 2011)
Volume 140, Issue 3, Pages (March 2011)
Volume 132, Issue 5, Pages (May 2007)
Volume 141, Issue 5, Pages e2 (November 2011)
Volume 129, Issue 2, Pages (August 2005)
Volume 128, Issue 3, Pages (March 2005)
Volume 129, Issue 3, Pages (September 2005)
Volume 132, Issue 5, Pages (May 2007)
Ribosomal Protein S3 Gene Silencing Protects Against Cigarette Smoke-Induced Acute Lung Injury  Jinrui Dong, Wupeng Liao, Hong Yong Peh, W.S. Daniel Tan,
Overexpression of CD109 in the Epidermis Differentially Regulates ALK1 Versus ALK5 Signaling and Modulates Extracellular Matrix Synthesis in the Skin 
Volume 131, Issue 6, Pages (December 2006)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 135, Issue 2, Pages e2 (August 2008)
Volume 122, Issue 7, Pages (June 2002)
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 133, Issue 6, Pages (December 2007)
Volume 138, Issue 4, Pages (April 2010)
Volume 8, Issue 5, Pages (May 2017)
Volume 139, Issue 4, Pages (October 2010)
Volume 140, Issue 1, Pages (January 2011)
Volume 139, Issue 2, Pages (August 2010)
Volume 136, Issue 7, Pages (June 2009)
Volume 13, Issue 6, Pages (November 2015)
Molecular Therapy - Methods & Clinical Development
Volume 24, Issue 1, Pages (January 2006)
CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4  Kandace Bonner,
Presentation transcript:

Volume 140, Issue 1, Pages 242-253 (January 2011) TGF-β2 Suppresses Macrophage Cytokine Production and Mucosal Inflammatory Responses in the Developing Intestine  Akhil Maheshwari, David R. Kelly, Teodora Nicola, Namasivayam Ambalavanan, Sunil K. Jain, Joanne Murphy–Ullrich, Mohammad Athar, Masako Shimamura, Vineet Bhandari, Charles Aprahamian, Reed A. Dimmitt, Rosa Serra, Robin K. Ohls  Gastroenterology  Volume 140, Issue 1, Pages 242-253 (January 2011) DOI: 10.1053/j.gastro.2010.09.043 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 (A) Macrophages in the preterm human intestine express TNF-α. Photomicrographs of jejunum (magnification 100×) show the distribution of immunoreactivity for the macrophage marker HAM56 (red) and TNF-α (green). Colocalization is shown in a computer-merged image (yellow). Macrophages in preterm (26-week premature infant) but not in the full-term intestine show strong immunoreactivity for TNF-α. Inset: high-magnification images (400×) of selected area highlight TNF-α expression in HAM56+ macrophages in the preterm intestine. (B) Macrophages isolated from the murine fetal intestine express TNF-α on LPS stimulation in vitro. Bar diagram shows TNF-α concentration (mean ± standard error of the mean) in culture supernatants from primary murine intestinal macrophages. Macrophages from the embryonic day (E) 15 and E18 murine fetuses, but not those from the P1 pups or adult mice, show LPS-induced TNF-α expression. Photomicrographs above the bar diagram show colocalization of F4/80 (a murine macrophage marker) and TNF-α in the fetal, but not in adult murine intestinal macrophages. Inset: bar diagram shows that tissue-conditioned media prepared from the adult mouse intestine suppressed LPS-induced TNF-α production in E15 murine fetal intestinal macrophages. Experiments represent 3 T-CMs per group; replicates were averaged. DAPI, 4′,6-diamidino-2-phenylindole. P < .05 in Kruskal–Wallis H test. Gastroenterology 2011 140, 242-253DOI: (10.1053/j.gastro.2010.09.043) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 Human peripheral blood monocyte-derived macrophages develop LPS tolerance on exposure to media conditioned with human adult, but not fetal, intestinal tissue. (A) Bar diagrams show TNF-α, IL-6, IL-1β, and IL-8 concentrations (mean ± standard error of the mean [SEM]) in culture supernatants from monocyte-derived macrophages treated with T-CMs. Fetal T-CMs became more effective in suppressing macrophage cytokine production with gestational maturation but remained inferior to adult T-CMs. Data representative of 3 independent experiments, each performed with tissues from 3−5 fetuses per fetal group and 3 adults. (B) T-CM suppression of macrophage cytokine production shown in (A) correlated with a corresponding reduction in the neutrophil chemotactic activity of these culture supernatants. Bar diagram (mean ± SEM) shows the number of neutrophils migrating across a polycarbonate filter in a microchemotaxis chamber toward culture supernatants from experiments in (A). Data are representative of 3 independent experiments, each performed with 3−5 supernatants from each group; (C) unlike T-CMs prepared from adult intestinal tissue, fetal T-CMs did not block LPS-induced nuclear factor−κB (NF-κB) activation in macrophages. Bar diagram (mean ± SEM) shows ratio of phosphorylated total NF-κB p65. Data represent 3−4 T-CMs per group. All experimental groups in the 3 panels were compared by Kruska–Wallis H test. Gastroenterology 2011 140, 242-253DOI: (10.1053/j.gastro.2010.09.043) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 Media conditioned with human intestinal tissue induce LPS tolerance in human peripheral blood monocyte-derived macrophages by providing TGF-β. (A) TGF-β bioactivity, measured as activation of the platelet activator inhibitor-1 promoter in a luciferase assay, increases in intestinal tissue-conditioned media with maturation. Data represent n = 3−5 samples per group; (B) T-CM activation of Smad signaling in human monocyte-derived macrophages increases with maturation. Bar diagram shows densitometric analysis of blots (mean ± standard error of the mean [SEM]). Data are representative of 3 independent experiments, each performed with a distinct set of T-CMs and used 2 different monocyte donors; (C) T-CM suppression of LPS-induced cytokine production in human monocyte-derived macrophages was reversed by neutralization of TGF-β in the conditioned media. Bar diagram shows LPS-induced TNF-α (mean ± SEM) production in macrophages. Data represent n = 4−6 T-CMs per group. All experimental groups in the 3 panels were compared by Kruskal–Wallis H test. Gastroenterology 2011 140, 242-253DOI: (10.1053/j.gastro.2010.09.043) Copyright © 2011 AGA Institute Terms and Conditions

Figure 4 Media conditioned with human intestinal tissue suppress cytokine production in human monocyte-derived macrophages primarily via the TGF-β2 isoform: (A) messenger RNA expression of TGF-β2, but not of TGF-β1 or TGF-β3, increases with intestinal maturation. Data depicted as fold-change above 10- to 14-week fetal intestine (mean ± standard error of the mean [SEM]) and represent n = 3−4 per group; (B) TGF-β2 immunoreactivity (green) increases in the intestine with gestational maturation. TGF-β2 was detected in epithelium and in cells in the lamina propria. Nuclear staining (blue) was obtained with 4′,6-diamidino-2-phenylindole. (C) Concentrations of active and total TGF-β2 increased in tissue-conditioned media (T-CMs) with maturation. Bar diagrams show mean ± SEM. Data represent n = 3−5 per group; (D) TGF-β2 is the most important TGF-β isoform in T-CM down-regulation of macrophage cytokine production. We removed 2 of the 3 TGF-β isoforms by immunoprecipitation in separate T-CM aliquots to obtain T-CM derivatives containing only 1 of 3 TGF-β isoforms. Bar diagram (mean ± SEM) shows that T-CMs containing TGF-β2 were most effective in suppressing LPS-induced TNF-α production in macrophages. Data are representative of 3 independent experiments, each performed with T-CMs derived from 3−4 subjects in each group. (E) Recombinant TGF-β2 is the most potent of the 3 isoforms in suppressing LPS-induced TNF-α production in macrophages. Data are representative of 3 independent experiments. All experimental groups in the 3 panels were compared by Kruskal–Wallis H test. Gastroenterology 2011 140, 242-253DOI: (10.1053/j.gastro.2010.09.043) Copyright © 2011 AGA Institute Terms and Conditions

Figure 5 TGF-β2 expression is decreased in intestinal tissue-samples resected from patients with NEC: TGF-β2 expression in tissue samples of NEC (n = 8) was lower than in the mid-gestation fetal (n = 6) and preterm neonatal intestine (n = 5). Data show measurements by enzyme-linked immunosorbent assay (mean ± standard error of the mean). Insets show TGF-β2 messenger RNA expression (top left) and TGF-β bioactivity (top right). Groups were compared by Kruskal–Wallis H test. Gastroenterology 2011 140, 242-253DOI: (10.1053/j.gastro.2010.09.043) Copyright © 2011 AGA Institute Terms and Conditions

Figure 6 TGF-β protects mouse pups against NEC-like intestinal injury: (A) Loss of TGF-β signaling in mice worsened NEC-like intestinal injury induced by intraperitoneal administration platelet-activating factor (PAF) and LPS. Bar diagram (mean ± standard error of mean) shows the severity of mucosal injury on a 5-point scale in wild-type (WT) mice, transgenic DNIIR mice with a partial deficiency of TGF-β signaling (3 days of zinc supplementation), and DNIIR mice with complete disruption of TGF-β signaling (7 days of zinc supplementation); n = 18 mice per group. Injury scores in DNIIR mice treated with zinc for 3 or 7 days but not treated with PAF and LPS were similar to WT controls (0.24 ± 0.11 and 0.26 ± 0.20, respectively; not depicted in the bar diagram). Groups were compared by Kruskal–Wallis H test. (B) Enteral administration of TGF-β2 before PAF and LPS administration in mouse pups reduced the severity of NEC-like intestinal injury; n = 18 mice per group, comparison by Mann–Whitney U test. (C) Enteral administration of TGF-β2 once a day in formula-fed mouse pups reduced the severity of intestinal injury induced by hypoxic stress; n = 18 mice per group, comparison by Mann–Whitney U test. Gastroenterology 2011 140, 242-253DOI: (10.1053/j.gastro.2010.09.043) Copyright © 2011 AGA Institute Terms and Conditions

Figure 7 Incomplete development of macrophage tolerance to bacterial products predisposes the preterm intestine to NEC. In the mature intestine (schematic representation on the left), epithelial and stromal cell-derived TGF-β attenuates the inflammatory responses of intestinal macrophages to luminal bacteria or their products. In contrast, in the premature infant (right), the inflammatory responses of intestinal macrophages remain intact because TGF-β expression, and therefore, mucosal tolerance to bacterial products, are deficient. Bacterial products trigger an intense inflammatory reaction, causing widespread tissue damage. Enteral supplementation of recombinant TGF-β2 is a potential therapeutic strategy to prevent NEC in neonates. Gastroenterology 2011 140, 242-253DOI: (10.1053/j.gastro.2010.09.043) Copyright © 2011 AGA Institute Terms and Conditions